We validated the data with western blotting of RAB40A, SEMA6D, COL6A5, and TTR, which were chosen on the basis of their differential expression in the dataset, assay feasibility, and T1D relevance (Figure 4E). The gene discussed is SEMA6D; the disease is type 1 diabetes mellitus.